Data / Form D filings / ADYNXX, INC.
ADYNXX, INC.: Form D filings
ADYNXX, INC., a pharmaceuticals company in San Francisco, CA, filed 4 Form D notices with the SEC between 2010 and 2017. The latest, on January 19, 2017, reports $16 million sold of a $16 million offering to 3 investors.
Find out what ADYNXX, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 Pine Street, Suite 500, San Francisco, CA, 94111
- Phone
- (415) 512-7740
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1427066
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 19, 2017 | New notice | $15,999,999 | $15,999,999 | $0 | 3 | Dec 20, 2016 | sec.gov |
| Dec 27, 2010 | New notice | $15,803,857 | $4,803,858 | $10,999,999 | 8 | Dec 9, 2010 | sec.gov |
| Dec 8, 2010 | New notice | $39,098 | $39,098 | $0 | 10 | Aug 1, 2008 | sec.gov |
| Aug 3, 2010 | New notice | $740,560 | $740,560 | $0 | 8 | Nov 8, 2007 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donald Manning | Executive Officer | |
| Dennis Podlesak | Director | |
| Stan Abel | Director | |
| Julien Mamet | Executive Officer, Director | |
| Scott Harris | Executive Officer | |
| Eckard Weber | Director | |
| Rick Orr | Executive Officer, Director | |
| Heath Lukatch | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jan 16, 2017 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ADYNXX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.